Compound 1 arrested cell cycle in G1 phase and was selectively cytotoxic to multiple myeloma G4-containing cell lines, including the L363 cell line, but it had no effects on the CA46 Burkitt’s lymphoma cell line, being resistant overall to G4-mediated MYC inhibition [188]. The gene discussed is MYC; the disease is plasma cell myeloma.